Q2 2024

Filed Aug 9, 2024 · 10-Q · 40 days after period end · 0001493152-24-031000

Q2 2024 · 10-Q

Revenue—

Net Income

-$2.31M

N/M vs Q2 2023

EPS Diluted

-$15.27

N/M vs Q2 2023

Operating Income-$2,306,000N/M

Operating Cash Flowderived-$1,544,529N/M

Same quarter

Metric	Q2 2024	Q2 2023	Q2 2022	Q2 2021
Revenue	—	$13.16K	$30.39K	—
Net Income	-$2.31M	-$3.05M	-$3.59M	-$3.82M
EPS Diluted	-$15.27	-$1.51	-$1.85	-$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR